Singapore has authorised the use of the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15 years as the country tackles a recent increase of infections.
"The data showed that the Pfizer-BioNTech COVID-19 vaccine demonstrated high efficacy consistent with that observed in the adult population," the health ministry said in a statement, adding, "its safety profile is also consistent with the known safety profile in the adult population."
The government will also extend the interval between two-dose COVID-19 vaccines to six to eight weeks, from three to four weeks currently, it said.
Israel military strikes northern Gaza in heaviest shelling in weeks
Russian drone attack injures 7 in Ukraine's Odesa, officials say
Indian court extends pre-trial detention of opposition leader Kejriwal
Taiwan rattled by more than 200 quakes, but no major damage
Malaysian navy helicopters collide in mid-air, 10 killed
